Evolution of the Average Target: Harmonic Inc.

Evolution of the Target Price: Harmonic Inc.

Changes in Analyst Recommendations: Harmonic Inc.

375af6e1fdd69.TLTT59MajG9o450ahbKL9ByKZLHoT8N3UOv35mygFUY.HP_rrZ99uBoEjK9D8tDvoH_fAtmKG48PIbjFnzvRIghh-7aGuVTNJAyNzA~319009247706115cdfe84a9634159a19
01-15 Top Midday Stories: BlackRock Rises on Q4 Results; Amazon Challenges Saks Global Chapter 11 Plan; Ford-BYD Potential Deal MT
25-07-28 Harmonic Q2 revenue, adjusted EPS beat expectations RE
25-07-08 Wolfe Initiates Harmonic at Underperform With $7 Price Target MT
25-01-10 Barclays Downgrades Harmonic to Equalweight From Overweight, Adjusts Price Target to $14 From $17 MT
25-01-09 Barclays Downgrades Harmonic to Equalweight From Overweight, Adjusts Price Target to $14 From $17 MT
24-10-29 Jefferies Downgrades Harmonic to Hold From Buy, Price Target is $12.50 MT
24-10-29 Raymond James Downgrades Harmonic to Outperform From Strong Buy, Price Target is $14 MT
24-01-30 Raymond James Trims Price Target on Harmonic to $18 From $19, Maintains Strong Buy Rating MT
24-01-30 Rosenblatt Securities Cuts Harmonic Price Target to $16 From $18, Maintains Buy Rating MT
23-11-01 Barclays Adjusts Price Target on Harmonic to $14 From $20, Maintains Overweight Rating MT
23-08-10 Raymond James Upgrades Harmonic to Strong Buy From Outperform, Adjusts Price Target to $16 From $15 MT
23-08-01 Jefferies Adjusts Harmonic Price Target to $18 From $19, Maintains Buy Rating MT
23-08-01 Raymond James Adjusts Price Target on Harmonic to $15 From $17, Maintains Outperform Rating MT
23-08-01 Rosenblatt Securities Adjusts Harmonic Price Target to $18 From $22, Maintains Buy Rating MT
23-08-01 Needham Adjusts Harmonic's Price Target to $18 From $21, Keeps Buy Rating MT
23-08-01 Barclays Adjusts Harmonic's Price Target to $20 From $23, Keeps Overweight Rating MT
23-05-09 Rosenblatt Adjusts Price Target on Harmonic to $22 From $20, Maintains Buy Rating MT
23-05-09 Barclays Adjusts Price Target on Harmonic to $23 From $20, Keeps Overweight Rating MT
23-03-21 Northland Securities Adjusts Price Target on Harmonic to $23 From $20, Keeps Outperform Rating MT
23-01-31 Raymond James Adjusts Harmonic Price Target to $17 From $18, Maintains Outperform Rating MT
23-01-31 Barclays Adjusts Harmonic's Price Target to $20 From $17, Keeps Overweight Rating MT
23-01-24 Needham Adjusts Price Target on Harmonic to $19 From $17, Maintains Buy Rating MT
23-01-09 Jefferies Upgrades Harmonic to Buy From Hold, Price Target is $19 MT
22-12-16 LifeSci Capital Downgrades Third Harmonic Bio to Market Perform From Outperform MT
22-12-16 Morgan Stanley Downgrades Third Harmonic Bio to Equalweight From Overweight, Slashes Price Target to $5 From $34 MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+17.67%
+15.5%
+10.78%
+8.7%
+42.13%
+24.4%
+10.47%
+46.74%
+35.19%
+8.55%
Average +22.01%
Weighted average by Cap. +19.70%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
12.99USD
Average target price
15.29USD
Spread / Average Target
+17.67%
High Price Target
20.00USD
Spread / Highest target
+53.96%
Low Price Target
8.000USD
Spread / Lowest Target
-38.41%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Wolfe Research
Barclays
Jefferies & Co.
Raymond James
Rosenblatt Securities
Needham & Co.
Northland Securities
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
12.99USD
Average target price
15.29USD
Spread / Average Target
+17.67%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. HLIT Stock
  4. Consensus Harmonic Inc.